Dow Up1.13% Nasdaq Up1.41%

Albany Molecular Research Inc. (AMRI)

-NMS
23.26 Up 0.53(2.33%) 4:00PM EDT
|After Hours : 23.26 Up 0.00 (0.01%) 4:49PM EDT
Cash FlowGet Cash Flow for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2013Dec 31, 2012Dec 31, 2011
Net Income 12,680   (3,777) (32,296)
Operating Activities, Cash Flows Provided By or Used In
Depreciation16,402  17,332  17,970  
Adjustments To Net Income4,338  13,963  22,516  
Changes In Accounts Receivables(9,330)(13,568)2,726  
Changes In Liabilities8,686  3,497  (11,573)
Changes In Inventories(5,141)(3,577)(4,618)
Changes In Other Operating Activities541  1,467  3,794  
Total Cash Flow From Operating Activities 28,176   15,337   (1,481)
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures(11,135)(9,890)(10,837)
Investments -  213  15,227  
Other Cash flows from Investing Activities(111)(105)(423)
Total Cash Flows From Investing Activities (11,246) (9,782) 3,967  
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid -   -   -  
Sale Purchase of Stock24,463  531  671  
Net Borrowings149,927  (3,065)(7,370)
Other Cash Flows from Financing Activities -   -   -  
Total Cash Flows From Financing Activities 136,885   (2,534) (6,969)
Effect Of Exchange Rate Changes(1,180)288  (1,280)
Change In Cash and Cash Equivalents 152,635   3,309   (5,763)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.